Statistics

Total Visits

Views
A multicenter randomized study comparing temozolomide (TMZ) versus TMZ-plus-bevacizumab (BEV) before standard treatment in unresectable glioblastoma (GBM) patients (p): The GENOM 009 study by the GEINO group75

Select a period of time:

Number of views in the range

Views
A multicenter randomized study comparing temozolomide (TMZ) versus TMZ-plus-bevacizumab (BEV) before standard treatment in unresectable glioblastoma (GBM) patients (p): The GENOM 009 study by the GEINO group20

Views

Views
November 20252
December 20251
January 20264
February 20262
March 20266
April 20260
May 20265
Download CSV file
 untranslated
 untranslated

Top country views

Views
United States12
United Kingdom3
Mexico2
Argentina2
Bolivia1
 

Top cities views

Views
Chicago1
Concord1
Cuautitlán Izcalli1
Dallas1
La Paz1
Moreno1
Naperville1
Norfolk1
Villa Mercedes1